Ajax Health Closes $120M Series B Financing

Ajax Health, a Menlo Park, Calif.-based clinical-stage platform company focused on developing medical technologies, closed a $120m Series B financing.

Backers includes Iconiq Capital, HealthQuest Capital, Polaris Partners, WTI, and other individual and large family office investors as well as majority investor KKR and existing investor Aisling Capital.

Founded in 2017 by Duke Rohlen, a medical technology entrepreneur and executive, in partnership with KKR and Aisling Capital, Ajax focuses on investing in and accelerating innovative medical technology opportunities that address significant unmet clinical needs.

The company clusters its investments around therapeutic verticals, such as electrophysiology, and capitalizes on funding inefficiencies that stem from the scarcity of capital in the medical technology space.



Join the discussion